Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a novel class of hypoglycemic drugs, show excellent cardiovascular benefits, and have further improved heart failure outcomes, significantly reducing cardiovascular and all-cause mortality irrespective of diabetes status. However, the efficacy of SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huayang, Zhang, Yitao, Wang, Shunjun, Yue, Yuan, Liu, Quan, Huang, Suiqing, Peng, Huajing, Zhang, Yi, Zeng, Weijie, Wu, Zhongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591217/
https://www.ncbi.nlm.nih.gov/pubmed/34790128
http://dx.doi.org/10.3389/fphar.2021.756226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591217/
https://www.ncbi.nlm.nih.gov/pubmed/34790128
http://dx.doi.org/10.3389/fphar.2021.756226

Ejemplares similares